Table 3.
Bias and precision of abiraterone oral clearance at the population level and individual level, between-individual variability, and between-occasion variability
| Between-occasion variability | Number of patients in trial | Oral Clearance – Population level | Oral Clearance – Individual level | Between-individual variability | Between-occasion variability | Food effect | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bias | Precision | Bias | Precision | Bias | Precision | Bias | Precision | Bias | Precision | ||
| 10% | 20 | −32.3% | 37.1% | 1.5% | 14.5% | −44% | 45.6% | −30% | 40.7% | 2.65% | 9.95% |
| 50 | −36.6% | 37.8% | 1.3% | 14.6% | −43.6% | 44.5% | −25.8% | 30.8% | 4.42% | 7.42% | |
| 70 | −36.8% | 37.8% | 1.4% | 14.9% | −43.3% | 43.5% | −15.3% | 23.3% | 3.84% | 6.81% | |
| 25% | 20 | −31.7% | 36.6% | 3.3% | 19.6% | −45.1% | 45.9% | −5.85% | 18.8% | 2.36% | 11.8% |
| 50 | −36.3% | 37.6% | 1.2% | 18.9% | −42.4% | 42.8% | −5.51% | 14.6% | 4.16% | 8% | |
| 70 | −36.9% | 37.9% | 3.2% | 19.9% | −43 % | 43% | −3.08% | 14.8% | 3.61% | 7.22% | |
| 40% | 20 | −31% | 36.2% | 1.4% | 19.7% | −44.9% | 46.1% | −1.34% | 17.4% | 2.01% | 14.4% |
| 50 | −35.7% | 37.1% | 1.6% | 19.9% | −42.1% | 42.8% | −1.44% | 13.4% | 2.52% | 11.9% | |
| 70 | −37% | 38.1% | 4.4% | 19.6% | −42.6% | 43% | −1.11% | 11.6% | 2.64% | 8.6% | |